Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,723 | 518 | 98.7% |
| Education | $110.55 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,592 | 102 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,569 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,455 | 76 | $0 (2024) |
| Grifols USA, LLC | $780.03 | 58 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $622.89 | 37 | $0 (2024) |
| GENZYME CORPORATION | $472.60 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $396.17 | 24 | $0 (2024) |
| Electromed, Inc. | $303.80 | 17 | $0 (2024) |
| Mylan Specialty L.P. | $288.72 | 15 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $249.16 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,543 | 137 | GlaxoSmithKline, LLC. ($436.52) |
| 2023 | $2,719 | 158 | GlaxoSmithKline, LLC. ($505.63) |
| 2022 | $1,799 | 121 | AstraZeneca Pharmaceuticals LP ($372.94) |
| 2021 | $1,773 | 104 | Boehringer Ingelheim Pharmaceuticals, Inc. ($424.99) |
All Payment Transactions
520 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Immunology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Pulmonology | ||||||
| 11/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.47 | General |
| Category: Narcoplepsy | ||||||
| 11/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Immunology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 343 | 402 | $74,778 | $23,017 |
| 2022 | 5 | 274 | 323 | $54,280 | $18,377 |
| 2021 | 5 | 328 | 396 | $75,126 | $22,976 |
| 2020 | 9 | 484 | 575 | $103,006 | $28,282 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 186 | $45,145 | $14,110 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 82 | $14,104 | $4,355 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,042 | $1,804 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 27 | $5,130 | $1,619 | 31.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 28 | 28 | $2,380 | $584.25 | 24.5% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 42 | 47 | $1,457 | $439.31 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 13 | $520.00 | $105.24 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 158 | $34,197 | $11,886 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,480 | $2,444 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 30 | $4,705 | $1,719 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 19 | $3,130 | $1,192 | 38.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 35 | 36 | $3,032 | $581.77 | 19.2% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 52 | 56 | $1,736 | $553.70 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 254 | $52,611 | $17,506 | 33.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,436 | $2,661 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 27 | $3,807 | $1,271 | 33.4% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 41 | 41 | $3,444 | $799.92 | 23.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 46 | 47 | $6,828 | $739.24 | 10.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 224 | 307 | $63,549 | $19,164 | 30.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 48 | 48 | $15,024 | $4,071 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 46 | $6,486 | $1,901 | 29.3% |
| 94375 | Diagnostic testing in a pulmonary function lab | Office | 2020 | 62 | 62 | $5,208 | $1,373 | 26.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $6,202 | $719.46 | 11.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 25 | 27 | $3,996 | $548.50 | 13.7% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 33 | 33 | $925.98 | $253.78 | 27.4% |
About Stephanie Fields, APRN
Stephanie Fields, APRN is a Family healthcare provider based in Winchester, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518307560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Fields, APRN has received a total of $8,834 in payments from pharmaceutical and medical device companies, with $2,543 received in 2024. These payments were reported across 520 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,723).
As a Medicare-enrolled provider, Fields has provided services to 1,429 Medicare beneficiaries, totaling 1,696 services with total Medicare billing of $92,652. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Winchester, KY
- Active Since 07/04/2013
- Last Updated 03/04/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1518307560
Products in Payments
- DUPIXENT (Biological) $1,095
- TRELEGY ELLIPTA (Drug) $951.68
- OFEV (Drug) $871.91
- Prolastin-C Liquid (Biological) $780.03
- FASENRA (Biological) $649.77
- NUCALA (Biological) $554.77
- STIOLTO RESPIMAT (Drug) $549.08
- BREZTRI (Drug) $386.53
- TEZSPIRE (Biological) $371.28
- SMARTVEST (Device) $303.80
- GLASSIA (Biological) $219.05
- AIRSUPRA (Drug) $196.78
- Yupelri (Drug) $169.84
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $157.56
- OPSUMIT (Drug) $147.36
- WAKIX (Drug) $133.83
- ARALAST (Biological) $125.43
- SPIRIVA RESPIMAT (Drug) $122.90
- YUPELRI (Drug) $118.88
- Xolair (Biological) $110.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Winchester
Stewart Vickrey, Aprn, APRN
Family — Payments: $63,979
Stacy Konyar, Fnp-C, FNP-C
Family — Payments: $42,860
Mrs. Colleen Nappi, Np, NP
Family — Payments: $26,072
Mr. Robert Fox
Family — Payments: $14,379
Anne Solomon, Cfnp, CFNP
Family — Payments: $9,921
Sherrie Smith, Fnp-Bc, FNP-BC
Family — Payments: $8,518